- Division Head, Neonatology, Ann & Robert H. Lurie Children’s Hospital of Chicago
- Raymond & Hazel Speck Berry Board Designated Professorship in Neonatology, Ann & Robert H. Lurie Children’s Hospital of Chicago
- Professor of Pediatrics (Neonatology), Northwestern University Feinberg School of Medicine
Aaron Hamvas, MD, has a longstanding interest in genetic contributions to lung diseases that affect newborns, children, and adults. Dr. Hamvas has combined his clinical interests in the care of newborn respiratory diseases with an integrated investigative program to understand the modifiable factors that influence outcomes of newborns.
Education and Background
- Fellowship in Newborn Medicine, Washington University School of Medicine 1987–1990
- Residency in Pediatrics, St. Louis Children’s Hospital 1981–1984
- MD, Washington University in St. Louis School of Medicine 1981
- BS, Rensselaer Polytechnic Institute 1977
Pathogenic variants in pulmonary surfactant associated genes result in newborn respiratory distress but can also contribute to idiopathic pulmonary fibrosis in adults. Dr. Hamvas and his research team use exome sequencing to identify genes and gene pathways that might inform variability in penetrance of these mutations and provide further insights into the development of chronic lung disease (bronchopulmonary dysplasia) in premature newborns.
Dr. Hamvas and his research team are part of an NIH-funded clinical observational study that combines analysis of continuous physiologic data streams, echocardiographic measures, and measures of autonomic nervous system function to identify physiologic perturbations that have an impact on cardiac, respiratory, and neurologic outcomes of premature babies.
Integrated Analysis of Autonomic Biomarkers in Prematurity-related Ventilatory Control: Determination of Neurorespiratory Maturation and Predictors of Co-morbidity Risk
National Institutes of Health/National Heart, Lung, and Blood Institute
09/01/2016 → 08/31/2022